Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 378

1.

[Tumors of the thyroid gland. Proposal for the management and study of samples from patients with thyroid neoplasms].

Cameselle-Teijeiro JM, Bella Cueto MR, Eloy C, Abdulkader I, Amendoeira I, Matías-Guiu X, Sobrinho-Simões M.

Rev Esp Patol. 2020 Jan - Mar;53(1):27-36. doi: 10.1016/j.patol.2019.03.003. Epub 2019 May 7. Review. Spanish.

PMID:
31932006
2.

Cancer incidence after childhood irradiation for tinea capitis in a Portuguese cohort.

Antunes L, Bento MJ, Sobrinho-Simões M, Soares P, Boaventura P.

Br J Radiol. 2020 Jan;93(1105):20180677. doi: 10.1259/bjr.20180677. Epub 2019 Nov 11.

PMID:
31674803
3.

Cribriform-morular variant of thyroid carcinoma.

Cameselle-Teijeiro JM, Sobrinho-Simões M.

Pathologica. 2019 Mar;111(1):1-3. doi: 10.32074/1591-951X-66-18. No abstract available.

PMID:
31217615
4.

European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium.

Luster M, Aktolun C, Amendoeira I, Barczyński M, Bible KC, Duntas LH, Elisei R, Handkiewicz-Junak D, Hoffmann M, Jarząb B, Leenhardt L, Musholt TJ, Newbold K, Nixon IJ, Smit J, Sobrinho-Simões M, Sosa JA, Tuttle RM, Verburg FA, Wartofsky L, Führer D.

Thyroid. 2019 Jan;29(1):7-26. doi: 10.1089/thy.2017.0129. Epub 2019 Jan 7.

PMID:
30484394
5.

OPNa Overexpression Is Associated with Matrix Calcification in Thyroid Cancer Cell Lines.

Ferreira LB, Lima RT, Bastos ACSDF, Silva AM, Tavares C, Pestana A, Rios E, Eloy C, Sobrinho-Simões M, Gimba ERP, Soares P.

Int J Mol Sci. 2018 Sep 30;19(10). pii: E2990. doi: 10.3390/ijms19102990.

6.

TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma.

Penna GC, Pestana A, Cameselle JM, Momesso D, de Andrade FA, Vidal APA, Araujo Junior ML, Melo M, Fernandes PV, Corbo R, Vaisman M, Sobrinho-Simões M, Soares P, Vaisman F.

Endocrine. 2018 Sep;61(3):489-498. doi: 10.1007/s12020-018-1642-0. Epub 2018 Jun 15.

PMID:
29948935
7.

Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway.

Cameselle-Teijeiro JM, Peteiro-González D, Caneiro-Gómez J, Sánchez-Ares M, Abdulkader I, Eloy C, Melo M, Amendoeira I, Soares P, Sobrinho-Simões M.

Mod Pathol. 2018 Aug;31(8):1168-1179. doi: 10.1038/s41379-018-0070-2. Epub 2018 May 21. Review.

8.

mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression.

Tavares C, Eloy C, Melo M, Gaspar da Rocha A, Pestana A, Batista R, Bueno Ferreira L, Rios E, Sobrinho Simões M, Soares P.

Int J Mol Sci. 2018 May 13;19(5). pii: E1448. doi: 10.3390/ijms19051448.

9.

Telomere Maintenance Mechanisms in Cancer.

Gaspar TB, Sá A, Lopes JM, Sobrinho-Simões M, Soares P, Vinagre J.

Genes (Basel). 2018 May 3;9(5). pii: E241. doi: 10.3390/genes9050241. Review.

10.

Genomic and transcriptomic characterization of the mitochondrial-rich oncocytic phenotype on a thyroid carcinoma background.

Cavadas B, Pereira JB, Correia M, Fernandes V, Eloy C, Sobrinho-Simões M, Soares P, Samuels DC, Máximo V, Pereira L.

Mitochondrion. 2019 May;46:123-133. doi: 10.1016/j.mito.2018.04.001. Epub 2018 Apr 6.

PMID:
29631022
11.

Age-Associated Mortality Risk in Papillary Thyroid Cancer: Does BRAF Make a Real Difference?

Melo M, Gaspar da Rocha A, Cancela E Penna G, Sobrinho-Simões M, Soares P.

J Clin Oncol. 2018 May 10;36(14):1455-1456. doi: 10.1200/JCO.2018.77.8571. Epub 2018 Mar 23. No abstract available.

PMID:
29570419
12.

Multinodular Goiter Progression Toward Malignancy in a Case of DICER1 Syndrome: Histologic and Molecular Alterations.

Gullo I, Batista R, Rodrigues-Pereira P, Soares P, Barroca H, do Bom-Sucesso M, Sobrinho-Simões M.

Am J Clin Pathol. 2018 Mar 29;149(5):379-386. doi: 10.1093/ajcp/aqy004.

PMID:
29538609
13.

Dynamin-Related Protein 1 at the Crossroads of Cancer.

Lima AR, Santos L, Correia M, Soares P, Sobrinho-Simões M, Melo M, Máximo V.

Genes (Basel). 2018 Feb 21;9(2). pii: E115. doi: 10.3390/genes9020115. Review.

14.

Is Low-Dose Radiation Exposure a Risk Factor for Atherosclerotic Disease?

Boaventura P, Durães C, Mendes A, Costa NR, Chora I, Ferreira S, Araújo E, Lopes P, Rosa G, Marques P, Tavares S, Chaves V, Bettencourt P, Oliveira I, Costa F, Ramos I, Teles MJ, Guimarães JT, Sobrinho-Simões M, Soares P.

Radiat Res. 2018 Apr;189(4):418-424. doi: 10.1667/RR14942.1. Epub 2018 Feb 20.

PMID:
29461943
15.

Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): impact on the reclassification of thyroid nodules.

Amendoeira I, Maia T, Sobrinho-Simões M.

Endocr Relat Cancer. 2018 Apr;25(4):R247-R258. doi: 10.1530/ERC-17-0513. Epub 2018 Feb 9. Review.

PMID:
29439059
16.

New WHO classification of thyroid tumors: a pragmatic categorization of thyroid gland neoplasms.

Cameselle-Teijeiro JM, Sobrinho-Simões M.

Endocrinol Diabetes Nutr. 2018 Mar;65(3):133-135. doi: 10.1016/j.endinu.2017.11.012. Epub 2018 Feb 7. English, Spanish. No abstract available.

PMID:
29396216
17.

CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension.

Celestino R, Nome T, Pestana A, Hoff AM, Gonçalves AP, Pereira L, Cavadas B, Eloy C, Bjøro T, Sobrinho-Simões M, Skotheim RI, Soares P.

BMC Cancer. 2018 Jan 10;18(1):68. doi: 10.1186/s12885-017-3948-3.

18.

NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features.

Tavares C, Coelho MJ, Eloy C, Melo M, da Rocha AG, Pestana A, Batista R, Ferreira LB, Rios E, Selmi-Ruby S, Cavadas B, Pereira L, Sobrinho Simões M, Soares P.

Endocr Connect. 2018 Jan;7(1):78-90. doi: 10.1530/EC-17-0302.

19.

Calcitonin receptor expression in medullary thyroid carcinoma.

Cappagli V, Potes CS, Ferreira LB, Tavares C, Eloy C, Elisei R, Sobrinho-Simões M, Wookey PJ, Soares P.

PeerJ. 2017 Sep 13;5:e3778. doi: 10.7717/peerj.3778. eCollection 2017.

20.

Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer.

Pópulo H, Nunes B, Sampaio C, Batista R, Pinto MT, Gaspar TB, Miranda-Alves L, Cai RZ, Zhang XY, Schally AV, Sobrinho-Simões M, Soares P.

Horm Cancer. 2017 Dec;8(5-6):314-324. doi: 10.1007/s12672-017-0307-4. Epub 2017 Sep 18.

PMID:
28924876
21.

European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics.

Paschke R, Cantara S, Crescenzi A, Jarzab B, Musholt TJ, Sobrinho Simoes M.

Eur Thyroid J. 2017 Jul;6(3):115-129. doi: 10.1159/000468519. Epub 2017 May 19.

22.

Accounting for tissue heterogeneity in infrared spectroscopic imaging for accurate diagnosis of thyroid carcinoma subtypes.

Martinez-Marin D, Sreedhar H, Varma VK, Eloy C, Sobrinho-Simões M, Kajdacsy-Balla A, Walsh MJ.

Vib Spectrosc. 2017 Jul;91:77-82. doi: 10.1016/j.vibspec.2016.09.014. Epub 2016 Sep 16.

23.

Etiopathogenesis of oncocytomas.

Correia M, Pinheiro P, Batista R, Soares P, Sobrinho-Simões M, Máximo V.

Semin Cancer Biol. 2017 Dec;47:82-94. doi: 10.1016/j.semcancer.2017.06.014. Epub 2017 Jul 4. Review.

PMID:
28687249
24.

The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications.

Rodrigues AC, Penna G, Rodrigues E, Castro P, Sobrinho-Simões M, Soares P.

Curr Genomics. 2017 Jun;18(3):244-254. doi: 10.2174/1389202918666170105094459. Review.

25.

TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.

Melo M, Gaspar da Rocha A, Batista R, Vinagre J, Martins MJ, Costa G, Ribeiro C, Carrilho F, Leite V, Lobo C, Cameselle-Teijeiro JM, Cavadas B, Pereira L, Sobrinho-Simões M, Soares P.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):1898-1907. doi: 10.1210/jc.2016-2785.

PMID:
28323937
26.

EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE).

Oliveira G, Polónia A, Cameselle-Teijeiro JM, Leitão D, Sapia S, Sobrinho-Simões M, Eloy C.

Virchows Arch. 2017 May;470(5):517-525. doi: 10.1007/s00428-017-2095-1. Epub 2017 Feb 24.

PMID:
28236059
27.

Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.

Penna GC, Vaisman F, Vaisman M, Sobrinho-Simões M, Soares P.

Cytogenet Genome Res. 2016;150(3-4):194-207. doi: 10.1159/000456576. Epub 2017 Feb 24. Review.

28.

TERT biology and function in cancer: beyond immortalisation.

Pestana A, Vinagre J, Sobrinho-Simões M, Soares P.

J Mol Endocrinol. 2017 Feb;58(2):R129-R146. doi: 10.1530/JME-16-0195. Epub 2017 Jan 5. Review.

PMID:
28057768
29.

GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma.

Almeida LMCA, Silva R, Cavadas B, Lima J, Pereira L, Soares P, Sobrinho-Simões M, Lopes JM, Máximo V.

Histol Histopathol. 2017 Oct;32(10):1029-1040. doi: 10.14670/HH-11-863. Epub 2016 Dec 28.

PMID:
28028797
30.

Hobnail Variant of Papillary Thyroid Carcinoma: Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases.

Cameselle-Teijeiro JM, Rodríguez-Pérez I, Celestino R, Eloy C, Piso-Neira M, Abdulkader-Nallib I, Soares P, Sobrinho-Simões M.

Am J Surg Pathol. 2017 Jun;41(6):854-860. doi: 10.1097/PAS.0000000000000793.

PMID:
28009606
31.

Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas.

Pereira SS, Máximo V, Coelho R, Batista R, Soares P, Guerreiro SG, Sobrinho-Simões M, Monteiro MP, Pignatelli D.

J Cell Biochem. 2017 Aug;118(8):2064-2071. doi: 10.1002/jcb.25811. Epub 2017 Apr 21.

PMID:
27886397
32.

The biology and the genetics of Hürthle cell tumors of the thyroid.

Máximo V, Lima J, Prazeres H, Soares P, Sobrinho-Simões M.

Endocr Relat Cancer. 2016 Dec;23(12):X2. No abstract available.

PMID:
27807063
33.

In vitro transforming potential, intracellular signaling properties and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu and Arg886Trp.

Prazeres H, Couto JP, Rodrigues F, Vinagre J, Torres J, Trovisco V, Martins TC, Sobrinho-Simões M, Soares P.

Endocr Relat Cancer. 2016 Dec;23(12):X1. No abstract available.

PMID:
27807062
34.

TERT promoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation.

Boaventura P, Batista R, Pestana A, Reis M, Mendes A, Eloy C, Sobrinho-Simões M, Soares P.

Eur J Endocrinol. 2017 Jan;176(1):49-55. Epub 2016 Oct 19.

PMID:
27760791
35.

IL6-174 G>C Polymorphism (rs1800795) Association with Late Effects of Low Dose Radiation Exposure in the Portuguese Tinea Capitis Cohort.

Boaventura P, Durães C, Mendes A, Costa NR, Chora I, Ferreira S, Araújo E, Lopes P, Rosa G, Marques P, Bettencourt P, Oliveira I, Costa F, Ramos I, Teles MJ, Guimarães JT, Sobrinho-Simões M, Soares P.

PLoS One. 2016 Sep 23;11(9):e0163474. doi: 10.1371/journal.pone.0163474. eCollection 2016.

36.

pmTOR is a marker of aggressiveness in papillary thyroid carcinomas.

Tavares C, Coelho MJ, Melo M, da Rocha AG, Pestana A, Batista R, Salgado C, Eloy C, Ferreira L, Rios E, Sobrinho-Simões M, Soares P.

Surgery. 2016 Dec;160(6):1582-1590. doi: 10.1016/j.surg.2016.06.050. Epub 2016 Aug 26.

PMID:
27574774
37.

Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells.

Prazeres H, Torres J, Rodrigues F, Pinto M, Pastoriza MC, Gomes D, Cameselle-Teijeiro J, Vidal A, Martins TC, Sobrinho-Simões M, Soares P.

Oncogene. 2017 Jan 5;36(1):146. doi: 10.1038/onc.2016.143. Epub 2016 Aug 8. No abstract available.

PMID:
27499094
38.

Corrigendum to "How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer".

Prazeres H, Torres J, Rodrigues F, Couto JP, Vinagre J, Sobrinho-Simões M, Soares P.

J Thyroid Res. 2016;2016:2168046. doi: 10.1155/2016/2168046. Epub 2016 Jun 28.

39.

TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes.

Vinagre J, Nabais J, Pinheiro J, Batista R, Oliveira RC, Gonçalves AP, Pestana A, Reis M, Mesquita B, Pinto V, Lyra J, Cipriano MA, Ferreira MG, Lopes JM, Sobrinho-Simões M, Soares P.

Sci Rep. 2016 Jul 14;6:29714. doi: 10.1038/srep29714.

40.

Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior.

Ferreira LB, Tavares C, Pestana A, Pereira CL, Eloy C, Pinto MT, Castro P, Batista R, Rios E, Sobrinho-Simões M, Gimba ER, Soares P.

Oncotarget. 2016 Aug 9;7(32):52003-52016. doi: 10.18632/oncotarget.10468.

41.

The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.

Batista R, Cruvinel-Carloni A, Vinagre J, Peixoto J, Catarino TA, Campanella NC, Menezes W, Becker AP, de Almeida GC, Matsushita MM, Clara C, Neder L, Viana-Pereira M, Honavar M, Castro L, Lopes JM, Carvalho B, Vaz RM, Máximo V, Soares P, Sobrinho-Simões M, Reis RM, Lima J.

Int J Cancer. 2016 Jul 15;139(2):414-23. doi: 10.1002/ijc.30057. Epub 2016 Mar 24.

42.

Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma.

Ferreira LB, Eloy C, Pestana A, Lyra J, Moura M, Prazeres H, Tavares C, Sobrinho-Simões M, Gimba E, Soares P.

Eur J Endocrinol. 2016 Apr;174(4):551-61. doi: 10.1530/EJE-15-0577. Epub 2016 Jan 25.

PMID:
26811408
43.

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

Shi X, Liu R, Basolo F, Giannini R, Shen X, Teng D, Guan H, Shan Z, Teng W, Musholt TJ, Al-Kuraya K, Fugazzola L, Colombo C, Kebebew E, Jarzab B, Czarniecka A, Bendlova B, Sykorova V, Sobrinho-Simões M, Soares P, Shong YK, Kim TY, Cheng S, Asa SL, Viola D, Elisei R, Yip L, Mian C, Vianello F, Wang Y, Zhao S, Oler G, Cerutti JM, Puxeddu E, Qu S, Wei Q, Xu H, O'Neill CJ, Sywak MS, Clifton-Bligh R, Lam AK, Riesco-Eizaguirre G, Santisteban P, Yu H, Tallini G, Holt EH, Vasko V, Xing M.

J Clin Endocrinol Metab. 2016 Jan;101(1):264-74. doi: 10.1210/jc.2015-2917. Epub 2015 Nov 3.

44.

ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome.

Tavares C, Melo M, Cameselle-Teijeiro JM, Soares P, Sobrinho-Simões M.

Eur J Endocrinol. 2016 Apr;174(4):R117-26. doi: 10.1530/EJE-15-0605. Epub 2015 Oct 28. Review.

PMID:
26510840
45.

Poorly Differentiated and Undifferentiated Thyroid Carcinomas.

Eloy C, Ferreira L, Salgado C, Soares P, Sobrinho-Simões M.

Turk Patoloji Derg. 2015;31 Suppl 1:48-59. doi: 10.5146/tjpath.2015.01314. Review.

46.

Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration.

Ferreira-da-Silva A, Valacca C, Rios E, Pópulo H, Soares P, Sobrinho-Simões M, Scorrano L, Máximo V, Campello S.

PLoS One. 2015 Mar 30;10(3):e0122308. doi: 10.1371/journal.pone.0122308. eCollection 2015.

47.

RE: TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.

Pópulo H, Lopes JM, Sobrinho-Simões M, Soares P.

J Natl Cancer Inst. 2015 Mar 9;107(4). pii: djv049. doi: 10.1093/jnci/djv049. Print 2015 Apr. No abstract available.

PMID:
25755155
48.

Next-generation pathology--surveillance of tumor microecology.

Koos B, Kamali-Moghaddam M, David L, Sobrinho-Simões M, Dimberg A, Nilsson M, Wählby C, Söderberg O.

J Mol Biol. 2015 Jun 5;427(11):2013-22. doi: 10.1016/j.jmb.2015.02.017. Epub 2015 Feb 26. Review.

49.

Coexistence of TERT promoter and BRAF mutations in papillary thyroid carcinoma: added value in patient prognosis?

Melo M, da Rocha AG, Vinagre J, Sobrinho-Simões M, Soares P.

J Clin Oncol. 2015 Feb 20;33(6):667-8. doi: 10.1200/JCO.2014.59.4614. Epub 2015 Jan 20. No abstract available.

PMID:
25605839
50.

An extraordinary case of mesenchymal chondrosarcoma metastasis in the thyroid.

Ortiz S, Tortosa F, Sobrinho Simões M.

Endocr Pathol. 2015 Mar;26(1):33-6. doi: 10.1007/s12022-014-9351-6.

PMID:
25510635

Supplemental Content

Loading ...
Support Center